Cargando…
Insulin Glargine and Cancer Risk in Patients with Diabetes: A Meta-Analysis
AIM: The role of insulin glargine as a risk factor for cancer is controversial in human studies. The aim of this meta-analysis was to evaluate the relationship between insulin glargine and cancer incidence. METHODS: All observational studies and randomized controlled trials evaluating the relationsh...
Autores principales: | Tang, Xulei, Yang, Lin, He, Zhiyu, Liu, Jingfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526637/ https://www.ncbi.nlm.nih.gov/pubmed/23284776 http://dx.doi.org/10.1371/journal.pone.0051814 |
Ejemplares similares
-
Insulin glargine and the risk of cancer
por: Ahmed, FA
Publicado: (2010) -
Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus
por: Linnebjerg, Helle, et al.
Publicado: (2016) -
Insulin Glargine and Acarbose in the treatment of elderly patients with diabetes
por: Li, Jing, et al.
Publicado: (2019) -
Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes
por: Tarigan, Tri Juli Edi, et al.
Publicado: (2021) -
A Salutary Tale—Glargine insulin and cancer risk
por: Boyle, Peter
Publicado: (2009)